Acrobat Genomics
Designing the future of programmable biology
health AImedtechbiotech
StageSeed / Grant-backed
Founded2022
Employees5
LocationSan Carlos, CA
Business modelB2B, likely SaaS/platform with collaborations
About
Acrobat Genomics builds AI-driven protein and genome engineering platforms for pharma, biotech, and research institutions. The company's AcrobaTx Engine is a closed-loop system that uses AI to propose therapeutic candidates, screens designs through parallel testing, measures functional data from human cells, and feeds results back to train the next cycle. Based in San Carlos, California, Acrobat Genomics has published peer-reviewed research on computationally guided protein engineering and genome editing tools.
Product
- Value proposition
- AI-powered protein engineering platform for programmable biology enabling rapid discovery and design of biological therapeutics and inhibitors
- Target customers
- pharma/biotech companies, research institutions
Founders
- Nick Hughes — Co-founder and CEO
- Muni Nakamura (also listed as Muneaki Nakamura) — Co-founder and CSO
Categories
biotechAI in biologygenomicsprotein engineeringdrug discovery
Products
AcrobaTx EngineAI-guided protein engineering platformpeer-reviewed scientific outputs (case studies)
Key features
closed-loop AI-driven protein engineeringhigh-throughput design and testingintegration of computational design with experimental validationmultidisciplinary team and advisory boardpeer-reviewed publications highlighting computational design of genome editing tools
Technologies
AI/MLcomputational protein designhigh-throughput screeninggenome editing tools (CRISPR-related)
Partnerships
Bruker Spatial Biology collaborationIllumina collaborationStanford Medicine collaborationDARPA RIDDL program
Traction metrics
Phase I completed (April 2026) in RIDDL programNIH award for therapeutic platform applications (Aug 2025)industry collaborations and peer-reviewed outputs
News
- Acrobat Genomics 2026 Company Profile - PitchBook · 2025-07-08T00:00:00.000Z
- GLIDE Teaming Profiles - ARPA-H · 2025-01-21T00:00:00.000Z
- Acrobat Genomics Advances to Next Phase of AI-Powered Inhibitor Discovery Program - San Francisco Biotechnology Network | Bay Area Life Science News, Jobs & Events · 2026-04-29T13:06:29.000Z
- Acrobat Genomics Advances to Next Phase of AI-Powered Inhibitor Discovery Program - MedicaEx.com · 2026-04-29T20:56:00.000Z
- Precision Medicine Revolution: Genetic Therapies with Sophia Lugo · 2026-03-11T00:00:00.000Z
Browse similar startups
Related startups
- Ahara Med | Ahara Nutrition — Los Angeles, CA
- AI Tensors, Corp. (Aka: AITCare) — San Francisco, CA
- AivoCode — San Diego, CA
- Aizen Therapeutics — San Diego, CA
- Alcance Genomics LLC — San Diego, CA
- Alchemy — San Francisco, CA
- Arialys Therapeutics — La Jolla, CA
- BlissGene Therapeutics Incorporated — Watertown, CT
- Duo Oncology — Pittsburgh, PA
- Entirety Biomedical — Newark
- Episteme Prognostics, Inc. — Brooklyn, NY
- Exactics, Inc. — Chicago, IL
Profile updated Jul 29, 2026. Sources: acrobatgenomics.com, linkedin.com
